Other Industries News & Press Release Distribution

Other Industries

Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform

- SupportingRakuten Medical’s efforts to accelerate its global Phase 3 studywith the goal of achieving approval of ASP-1929 in US as soon as possible - Also supporting development of additional pipeline using the Alluminox™ platform, including ASP-1929 photoimmunotherapy in combination with anti-P...

2024-03-07 11:27

Comparing ESG Regulations in the U.S., the U.K., and the EU

Environmental, social, and corporate governance (ESG) is a rapidly evolving framework designed to hold companies accountable for their actions and increase understanding of how an organization or company manages its risks around these issues. In a perfect world, ESG knowledge would increase investor...

2023-04-06 11:26

Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi

Born and raised in Japan, Takashi “Tora” Toraishi has a master's degree and a Ph.D. from the University of Tokyo, in nuclear chemistry. Before he joined Rakuten Medical, Tora worked in the molecular biology and chemistry field. He acted as a partner for McKinsey & Company, providing management consu...

2023-04-06 11:24

2023 Trend Forecast: Transforming Healthcare with Real-world Data and Personalized Medicine

By the end of 2022, while the global COVID-19 pandemic seemed to be subsiding, the development of the biotech and healthcare industry has kept up its pace over the past three years. Rather, consolidation efforts have been accelerated in specific areas, especially the integration of healthcare and te...

2023-01-31 15:47

Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)

The Institute of Biological Chemistry (IBC), Academia Sinica, National Taiwan University Hospital (NTUH), and BIOTOOLS hosted the 7th annual Asia Microbiome Conference (AMC) on January 7th, 2023, at Academia Sinica, Taiwan. With over 400 hundred domestic and foreign microbiome experts participating ...

2023-01-31 15:38

Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding

Established in February 2020, Micronbrane Medical is a Taiwan-based biotechnology startup company dedicated to the development of precision medicine. With an international team of scientists, engineers and innovators, the company is focused on the development of clinical pathogen diagnostic a...

2022-12-08 10:15

$Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding$

RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022

PHILADELPHIA –RemeGenattended the American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2022, from Nov 10-14, to present promising phase III trial data for SLE which met its primary endpoint, and phase II trial data for primary Sjogren’s syndrome which showed encouraging sa...

2022-12-08 10:11

RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022

Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare

It is no news that the childbirth rate is declining each year. However, you might not realize that it has reached a point where the number of pets is more than the number of children under the age of 15 for the first time in Taiwan’s history in 2020. What’s more, according to Taiwan’s Pets Re...

2022-12-08 10:09

Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare

RemeGen Looks to Take Next Global Steps During ASN Kidney Week 2022

ORLANDO, FL – RemeGen officials look to partner with a global pharmaceutical or biotech company to take their drug candidates to the next level during ASN Kidney Week 2022. “Having seen a lot of promising data having emerged from the completed, or even ongoing trials, it really brings us to looking...

2022-12-01 14:29

Moving Past Animal Models with Better Data for Drug Discovery

With the FDA Modernization Act’s passage earlier this year, drug developers have the opportunity to forgo animal models in preclinical development for the first time in history. While the bill provides reprieve for the millions of animals tested in laboratories, it also provides a chance for human a...

2022-12-01 14:29

Moving Past Animal Models with Better Data for Drug Discovery

Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates

“How does vision become reality?” Illumina CEO Francis deSouza posed this question at the beginning of the 2022 Illumina Genomics Forum hosted in San Diego, California. The first day of the four-day event saw deSouza’s introduction of the importance of genomics, followed by a panel hosted by Nobel L...

2022-12-01 14:27

Coastar Therapeutics Receives Venture Capital Investment to Further Develop Delivery Technology of Biologics for Cancer and Gene Therapies

SAN DIEGO, Calif., November 10, 2022 — Coastar Therapeutics, a biotechnology company and emerging leader in biologic drug delivery technology, today announced it has successfully completed the first close of its Series Pre-A financing. The multi-million dollar investment was led by Panacea Venture a...

2022-11-11 17:09

Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene

The recent progress in cell and gene therapies, particularly that of autologous CAR-T therapy, has brought revolutionary advances to medicine. However, due to the variability of the donor source and manufacturing processes, these new treatments come with financial limitations and safety concerns. Gl...

2022-10-26 17:23

Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene

Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy

Head and neck cancer, the seventh largest cancer globally, typically arises from the head and neck region, with 90% of the carcinoma originating from squamous cells. Since head and neck cancer includes cancers in various subsites, like the tongue, pharyngeal, laryngeal, and nasal cavities, the sympt...

2022-09-29 16:31

Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy

BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry

BIOPLUS-INTERPHEX KOREA (BIX) was held from August 3-5 in person at COEX, Seoul. With the theme, K-BIO Value Chain, the event encompasses biopharmaceutical value chains, including R&D, manufacturing process, logistics, packaging, CMO/CDMO, AI, and big data. In the opening ceremony, Christopher Han...

2022-08-26 11:02

BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry

NIH Provides $23 Million to Fund Telehealth Cancer Care Research

In an effort to establish a more robust framework for digital healthcare in the cancer care space, the National Cancer Institute, part of the National Institutes of Health, is laying down $23 million to four organizations to fund research efforts. The funding aims better to understand telehealth ope...

2022-08-26 11:00

Single Cell Sequencing – the Current Players

Normally, a mix of millions of cells is analyzed using traditional DNA or RNA sequencing methods via Sanger sequencing or high-throughput synthesis. But now, with single cell sequencing, we can investigate DNA and RNA from a single cell, unraveling cellular functions one base pair at a time. The sin...

2022-08-10 10:42

Single Cell Sequencing – the Current Players

Korean Companies Occupying South Korea’s Diverse Biotech Landscape

In face of the COVID-19 pandemic, South Korea’s biotech companies have risen to the challenge of supplying the world’s vaccines, and the region is on the path to becoming one of the leading biologics manufacturers. The Korean government is actively introducing policies that favor biotech development...

2022-08-10 10:41

South Korea’s Biotech Industry：Trends, Landscape, and Clusters Overview

While the global pharmaceutical industry is facing enormous challenges in operation and R&D innovation due to the changing global trend, the South Korean pharmaceutical industry is also facing severe difficulties such as reduced production capacity, tightened regulations, insufficient innovation, an...

2022-08-10 10:37

South Korea’s Biotech Industry：Trends, Landscape, and Clusters Overview

Caliway Biopharmaceutical Announces Achievements in Revolutionary Fat Reduction Therapy

Caliway Biopharmaceutical Inc (CBI) has announced that its first pipeline, CBL-514 has demonstrated promising clinical effectiveness and safety in reducing local fat through a mechanism of adipocytes apoptosis. Current Treatment Options for Fat Reduction Localized adiposity is often diet and exer...

2022-08-10 10:26

Caliway Biopharmaceutical Announces Achievements in Revolutionary Fat Reduction Therapy

12 3 4 5